Lipitor: Brand Profile

Cholesterol-reducing Lipitor is the world's most successful pharmaceutical product by lifetime sales, and still - for now - ranks among drugs giant Pfizer's portfolio of blockbusters. It was the first drug ever to exceed sales of $10bn per year and at its peak in 2006 it accounted for more than a quarter of Pfizer's annual sales, and around 40% of all prescriptions for lipid-lowering medications, more than twice as much as its closest rival. However its share has slipped considerably since then, first with the emergence of low-cost generic competitors to rival products, and more recently from expiry of its own patent in November 2011. Although it remains a giant within the industry, sales for 2015 had fallen to less than a sixth of their former high.

Which agencies handle advertising for Lipitor? Find out more from the Account Assignments database.

Who are the competitors of Lipitor? See Pharmaceutical Sector index for other companies    

Subscribers only: Adbrands profile Account assignments and selected contact information

Adbrands Company Profiles provide a detailed analysis of the history and current operations of leading advertisers, agencies and brands worldwide, and include a critical summary which identifies key strengths and weaknesses. Adbrands Account Assignments tracks account management for the world's leading brands and companies, including details of which advertising agency handles which accounts in which countries for major markets. 

Subscribers may access the following website links here:

Lipitor website


Click HERE to subscribe to and access the profile and website links All rights reserved Mind Advertising Ltd 1998-2018